The Food and Drug Administration (FDA) has approved Tecentriq Hybreza ™ (atezolizumab and hyaluronidase-tqjs) for subcutaneous (SC) injection, for all the approved adult indications of intravenous ...
GSK today announced results from the BLISS-SC Phase III pivotal study in patients with active, autoantibody-positive systemic lupus erythematosus (SLE). These results ...
Efgartigimod given subcutaneously with hyaluronidase PH20 is as effective as IV efgartigimod in reducing total IgG levels, preliminary findings show. PHOENIX, Arizona—Efgartigimod given subcutaneously ...
A subcutaneous injection, or shot, enters the fatty tissues just beneath the skin. It is shallower than an injection into muscle tissue. Healthcare professionals often use subcutaneous injections for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results